Orion Biotech Opportunities Other Assets

Orion Biotech Opportunities posts a other assets of $0 as of December 2022. That compares with $200M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Orion Biotech Opportunities's other assets was $200M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending December 2022). Use the history and growth charts on this page for a longer lookback.

Other Assets is one piece of Orion Biotech Opportunities's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ORIA's other assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Orion Biotech Opportunities's other metric pages and overview cover the third.